Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 6 results:
Συντάκτης Τίτλος Τύπος [ Έτος![(Asc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-asc.png)
Φίλτρα: Συντάκτης is Kotoula, Vassiliki and Keyword is Carcinoma [Clear All Filters]
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression..
Clin Breast Cancer. 12(3), 183-93.
(2012). Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib..
Clin Cancer Res. 15(23), 7153-60.
(2009).
(2008).
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition..
J Clin Endocrinol Metab. 92(12), 4845-52.
(2007). Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro..
J Clin Endocrinol Metab. 91(10), 4013-21.
(2006). Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis..
J Clin Endocrinol Metab. 91(9), 3662-6.
(2006).